Literature DB >> 30401969

Late relapse after stopping sorafenib in allogeneic hematopoietic stem cell transplant recipients.

S Gerull1, A Tschan-Plessl2, R Mathew2, G Nair3, J R Passweg2, J P Halter2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30401969     DOI： 10.1038/s41409-018-0376-1

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  1 in total

1.  A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation.

Authors:  Keith W Pratz; Michelle A Rudek; B Douglas Smith; Judith Karp; Ivana Gojo; Amy Dezern; Richard J Jones; Jackie Greer; Christopher Gocke; Maria R Baer; Vu H Duong; Gary Rosner; Marianna Zahurak; John J Wright; Ashkan Emadi; Mark Levis
Journal:  Biol Blood Marrow Transplant       Date:  2019-09-21       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.